Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.08 USD | +1.55% | +5.45% | -6.24% |
May. 02 | Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating | MT |
May. 01 | Top Midday Gainers | MT |
Financials (USD)
Sales 2024 * | 123M | Sales 2025 * | 138M | Capitalization | 486M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -2M | EV / Sales 2024 * | 3.95 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.53 x |
P/E ratio 2024 * |
-43.8
x | P/E ratio 2025 * |
-220
x | Employees | 376 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.26% |
Latest transcript on Surmodics, Inc.
1 day | +1.55% | ||
1 week | +5.45% | ||
Current month | +32.66% | ||
1 month | +28.12% | ||
3 months | +8.92% | ||
6 months | +0.15% | ||
Current year | -6.24% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Maharaj
CEO | Chief Executive Officer | 61 | 10-12-26 |
Timothy Arens
DFI | Director of Finance/CFO | 57 | 07-01-31 |
Teri L. Sides
PRN | Corporate Officer/Principal | 55 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Kalich
BRD | Director/Board Member | 77 | 14-02-16 |
Susan Knight
CHM | Chairman | 70 | 08-01-28 |
José Bedoya
BRD | Director/Board Member | 68 | 01-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.21% | 25 M€ | -1.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 34.08 | +1.55% | 38,885 |
24-05-15 | 33.56 | +1.70% | 183,250 |
24-05-14 | 33 | +1.69% | 56,626 |
24-05-13 | 32.45 | +0.90% | 50,046 |
24-05-10 | 32.16 | -0.50% | 30,337 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.24% | 479M | |
-4.72% | 182B | |
+3.96% | 112B | |
-2.93% | 68.58B | |
+6.30% | 51.58B | |
+8.02% | 44.24B | |
+7.74% | 43.65B | |
+26.18% | 32.46B | |
+18.56% | 25.99B | |
+0.57% | 25.61B |
- Stock Market
- Equities
- SRDX Stock